title: Interceptor effect of C60 fullerene on the in vitro action of aromatic drug molecules.
abstract: C60 fullerenes are spherical molecules composed purely of carbon atoms. They inspire a particularly strong scientific interest because of their specific physico-chemical properties and potential medical and nanotechnological applications. In this work we are focusing on studying the influence of the pristine C60 fullerene on biological activity of some aromatic drug molecules in human buccal epithelial cells. Assessment of the heterochromatin structure in the cell nucleus as well as the barrier function of the cell membrane was performed. The methods of cell microelectrophoresis and atomic force microscopy were also applied. A concentration-dependent restoration of the functional activity of the cellular nucleus after exposure to DNA-binding drugs (doxorubicin, proflavine and ethidium bromide) has been observed in human buccal epithelial cells upon addition of C60 fullerene at a concentration of ~10(-5 )M. The results were shown to follow the framework of interceptor/protector action theory, assuming that non-covalent complexation between C60 fullerene and the drugs (i.e., hetero-association) is the major process responsible for the observed biological effects. An independent confirmation of this hypothesis was obtained via investigation of the cellular response of buccal epithelium to the coadministration of the aromatic drugs and caffeine, and it is based on the well-established role of hetero-association in drug-caffeine systems. The results indicate that C60 fullerene may reverse the effects caused by the aromatic drugs, thereby pointing out the potential possibility of the use of aromatic drugs in combination with C60 fullerene for regulation of their medico-biological action.
authors.affiliation: Department of Physics, Sevastopol National Technical University, Universitetskaya Str., 33, Sevastopol, 99053, Ukraine, galina_skamrova@mail.ru.
authors.forename: Galyna B
authors.initials: GB
authors.lastname: Skamrova
authors.forename: Ivan
authors.initials: I
authors.lastname: Laponogov
authors.forename: Anatoly S
authors.initials: AS
authors.lastname: Buchelnikov
authors.forename: Yuriy G
authors.initials: YG
authors.lastname: Shckorbatov
authors.forename: Svitlana V
authors.initials: SV
authors.lastname: Prylutska
authors.forename: Uwe
authors.initials: U
authors.lastname: Ritter
authors.forename: Yuriy I
authors.initials: YI
authors.lastname: Prylutskyy
authors.forename: Maxim P
authors.initials: MP
authors.lastname: Evstigneev
mesh_terms: D000328:Adult; D002110:Caffeine / Q000494:pharmacology; D004347:Drug Interactions; D004847:Epithelial Cells / Q000187:drug effects; D037741:Fullerenes / Q000494:pharmacology*; D006801:Humans; D006841:Hydrocarbons, Aromatic / Q000494:pharmacology*
chemical_list: D037741:Fullerenes; D006841:Hydrocarbons, Aromatic; D002110:Caffeine; C069837:fullerene C60
references.citation: FASEB J. 2010 Apr;24(4):1066-72
references.pmid: 19897663
references.citation: Curr Med Chem. 2011;18(14):2045-59
references.pmid: 21517770
references.citation: Biochem Biophys Res Commun. 2002 May 31;294(1):116-9
references.pmid: 12054749
references.citation: Eur Biophys J. 2012 Mar;41(3):273-83
references.pmid: 22213076
references.citation: Mech Ageing Dev. 1995 Sep 7;83(2):87-90
references.pmid: 8569288
references.citation: Regul Toxicol Pharmacol. 2010 Dec;58(3):455-73
references.pmid: 20800639
references.citation: Cancer Res. 1991 Jul 15;51(14):3682-9
references.pmid: 2065324
references.citation: Bioorg Med Chem. 2013 Jun 1;21(11):3280-9
references.pmid: 23601817
references.citation: Exp Oncol. 2011 Sep;33(3):162-4
references.pmid: 21956470
references.citation: Nano Lett. 2007 Mar;7(3):614-9
references.pmid: 17316055
references.citation: Int J Radiat Biol. 2009 Apr;85(4):322-9
references.pmid: 19399677
references.citation: Eur Biophys J. 2006 Dec;36(1):1-11
references.pmid: 17061089
references.citation: Biophys J. 2005 Dec;89(6):3856-62
references.pmid: 16183879
references.citation: Biophys J. 1996 Jan;70(1):443-52
references.pmid: 8770220
references.citation: Electrophoresis. 2002 Jul;23(13):2074-9
references.pmid: 12210261
references.citation: Chemphyschem. 2013 Feb 25;14(3):568-78
references.pmid: 23345058
references.citation: Biophys Chem. 2008 Feb;132(2-3):148-58
references.pmid: 18060679
references.citation: Eur Biophys J. 2011 Aug;40(8):969-80
references.pmid: 21674180
references.citation: Bioorg Chem. 2011 Feb;39(1):10-7
references.pmid: 21146849
references.citation: Cancer Nanotechnol. 2011;2(1-6):105-110
references.pmid: 26069489
references.citation: Phys Chem Chem Phys. 2013 Jun 21;15(23):9351-60
references.pmid: 23660696
references.citation: J Biomed Nanotechnol. 2012 Jun;8(3):522-7
references.pmid: 22764423